Bio-Banking for Advanced Lung Disease and Lung Transplant Research
This study, called a bio-banking registry, is collecting blood samples and health information from people with advanced lung diseases or those who have had a lung transplant. The goal is to better understand these conditions and improve care, especially by identifying biomarkers (signs in the body that can indicate disease or how it will progress). Researchers hope to learn more about how viruses and infections affect lung transplant patients. You may be able to join if you are 18 or older, have had a lung transplant at Baylor University Medical Center in the last 10 years, and can understand and sign the consent form. The study aims to enroll 100 participants. Success will be measured by the diagnosis of patients with lung transplant over a 5-year period.
- Study design
- This is an observational study, meaning researchers will collect information without giving any new treatments. It aims to enroll 100 participants.
- What's involved
- You would provide blood samples and clinical data at each blood collection visit.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint is measured at 5 years, suggesting a follow-up period of at least that long.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Susan Mathai, MD · PRINCIPAL_INVESTIGATOR · Baylor Scott & White Research Institute
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Diagnosis of patients with lung transplant5 years
ICD 10 code for underlying lung disease